CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
TD Cowen downgrades Novo Nordisk on concerns over semaglutide patent loss, pipeline outlook https://cnb.cx/4umJZGH
2026-03-10T11:36:39.149Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.